Sernova Retains FronTier Merchant Capital for North America Investor Relations and Marketing

Ontario Industry Updates
Written By Guest User

Sernova Corp, a leading clinical stage regenerative medicine company, announced that FronTier Merchant Capital Group will provide North American investor relations (IR) and strategic marketing for Sernova with a goal of increasing market awareness through financial market communications.

Read the full press release here.

Guest User
Previous

Canadian Mission to MassMEDIC's MedTech Showcase
Next

OBIO Companies Advance to Semi-Finals of 2017 Interface Health Challenge X